More good news with this acquisition of 7 new generic drugs and just listened to Art's presentation that was Very positive! I see it's down 7% pre market, unbelievable.
Chris Slavinsky - Vice President at Takeda's Center for External Innovation liked the deal. It may mean nothing, but it makes me wonder if Takeda is looking at an external partnership with ANIP.